Q32 Bio Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | -68.7% | +62.2% | +1,157.3% | -80.4% | -200.0% | – | – | |
| – | +185.3% | – | – | – | – | -72.8% | -80.8% | -2.4% | -19.7% | |
| – | – | – | -68.7% | +62.2% | +804.0% | -72.8% | -200.0% | – | – | |
| – | +275.4% | +124.3% | +86.4% | +12.3% | -70.2% | +19.7% | -11.4% | +51.7% | -60.2% | |
| – | – | – | – | – | – | +48.8% | -1.9% | +81.9% | -1.6% | |
| – | +196.9% | +120.8% | +64.6% | +17.8% | -70.4% | +25.0% | -9.3% | +58.9% | -44.3% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -26.7% | +0.0% | |
| – | – | – | – | – | – | – | – | – | – | |
| – | -300.0% | – | – | – | – | -88.7% | +412.9% | -93.4% | – | |
| – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.